确定pyrazinamide对Mycobacterium tuberculosis临床分离物的最小抑制度,在6.8的中性pH值下,使用微稀释方法

Maria Tamblin1, Wanliang Shi2, Liang Chen3

  • 1Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, United States.

Frontiers in microbiology
|November 6, 2025
PubMed
概括

准确的皮拉津胺胺 (PZA) 敏感性测试对于结核病治疗至关重要. 这项研究开发了一种可靠,具有成本效益的微稀释方法,在中性pH下用于检测Mycobacterium tuberculosis中的PZA耐药性.